Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06442033 · ClinicalTrials.gov registry record · NA

Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial

A NA study of Parkinson Disease, sponsored by Jay Alberts.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06442033 is a NA study of Parkinson Disease that is actively recruiting participants, run by Jay Alberts. The registered enrollment target is 200 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06442033, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Jay Alberts.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The proposed multi-site, Genetics and Aerobic Exercise to Slow PD (GEARS) Trial will, for the first time, determine the interplay between genetics and exercise in altering PD progression. In sum, 200 PD patients will be recruited from the Cleveland and Salt Lake City metro areas to participate in the Pedaling for Parkinson's (PFP) community-based exercise program. Participants will exercise at community-based sites 3x/week for 12 months. All participants will undergo genotyping using an array that includes the genome backbone and common risk variants associated to increase risk for multiple neurological disorders including PD.

Conditions Studied

Interventions

  • OTHER High intensity stationary cycling

Study Locations (1)

Ohio

  • The Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-08-23
Est. Completion 2028-12-31
Phase NA

Sponsor

Jay Alberts

3 total trials

What the Registry Record Tells You About NCT06442033

The ClinicalTrials.gov registry entry for NCT06442033 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The listed sponsor is Jay Alberts, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which High intensity stationary cycling is the first listed.

NCT06442033 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06442033 about?

NCT06442033 is a clinical study titled "Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial". The proposed multi-site, Genetics and Aerobic Exercise to Slow PD (GEARS) Trial will, for the first time, determine the interplay between genetics and exercise in altering PD progression. In sum, 200 PD patients will be recruited from the Cleveland and Salt Lake City metro areas to participate in th...

What is the current status of trial NCT06442033?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-08-23. Estimated completion is 2028-12-31.

What conditions does trial NCT06442033 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06442033?

The interventions under investigation include: High intensity stationary cycling (OTHER).

Who is sponsoring clinical trial NCT06442033?

This trial is sponsored by Jay Alberts, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06442033 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.